These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 10205169)
1. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. Siegel PM; Ryan ED; Cardiff RD; Muller WJ EMBO J; 1999 Apr; 18(8):2149-64. PubMed ID: 10205169 [TBL] [Abstract][Full Text] [Related]
2. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Siegel PM; Dankort DL; Hardy WR; Muller WJ Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors. Chan R; Muller WJ; Siegel PM Ann N Y Acad Sci; 1999; 889():45-51. PubMed ID: 10668481 [TBL] [Abstract][Full Text] [Related]
4. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Muller WJ; Ho J; Siegel PM Biochem Soc Symp; 1998; 63():149-57. PubMed ID: 9513719 [TBL] [Abstract][Full Text] [Related]
7. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933 [TBL] [Abstract][Full Text] [Related]
9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
10. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC; Springs AE; Chen WY Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488 [TBL] [Abstract][Full Text] [Related]
11. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development. Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720 [TBL] [Abstract][Full Text] [Related]
12. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. Campbell MJ; Wollish WS; Lobo M; Esserman LJ In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120 [TBL] [Abstract][Full Text] [Related]
13. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK; Muller WJ Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608 [TBL] [Abstract][Full Text] [Related]
14. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116 [TBL] [Abstract][Full Text] [Related]
15. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541 [TBL] [Abstract][Full Text] [Related]
16. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356 [TBL] [Abstract][Full Text] [Related]
17. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP; Kokeny KE; Ridings JW; Dilts CA Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031 [TBL] [Abstract][Full Text] [Related]
18. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells. Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963 [TBL] [Abstract][Full Text] [Related]